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H
ypoalbuminemia  is  a  common  and  vexing 
postoperative  complication.  In  some  case  ser-
ies, about 20% to 40% of patients sustained an 
acute, prolonged, and profound drop in serum albumin 
after elective surgery.1–3 Acute hypoalbuminemia is suf-
ficiently common in critical care as to be an established 
risk  factor  in  the  APACHE  index.4  Hypoalbuminemia 
can  lead  to  delayed  mobilization,  inadequate  vascular 
access and unnecessary doses of diuretics. Where does 
the albumin go?
The laws of physiology suggest that hypoalbuminemia 
reflects some combination of decreased albumin produc-
tion, increased losses, acute dilution or shifts from the 
vascular space.5 Low production is easy to hypothesize 
in a patient with anorexia. However, the half-life of al-
bumin is about 3 weeks.6 Hence, total starvation with 
zero production would not explain rapid-onset hypoal-
buminemia. Acute dilution could be rapid, yet it seems 
implausible in patients who have a normal hemoglobin 
and uric acid level after surgery.
One popular explanation relates to displacement into 
an extravascular space; however, three points indicate 
that this might not be the entire story. First, such a space 
should eventually become fully saturated, whereas end-
less  albumin  transfusions  generally  fail  to  increase  a 
patient’s serum albumin.7 Second, an inert space should 
also give back the sequestered albumin; however, it can 
take months before a patient’s serum albumin is fully 
normalized. Third, data from animal studies do not sup-
port the hypothesis of major redistribution.8
Classical  textbooks  also  mention  that  albumin  can 
be  lost  through  epidermal,  renal  or  gastrointestinal 
sources.9 Excess epidermal losses are generally implaus-
ible in the absence of burns, dermatitis or open wounds. 
Excess  renal  losses  are  easily  excluded  if  a  urinaly-
sis shows no proteinuria. The case for gastrointestinal 
losses is not compelling, since most patients manifest 
no vomiting, diarrhea, or abdominal pain. Such patients 
with postoperative hypoalbuminemia have the markings 
of an enigma. 
Many  other  sick  patients  also  develop  unexplained 
hypoalbuminemia. Septic patients in intensive care are no-
torious for albumin levels as low as 10 g/L.10 Patients with 
acute trauma seen in the emergency department are also 
classic for developing hypoalbuminemia soon after injury—
a scenario that does not reflect dilution.11 In all cases, the 
hypoalbuminemia is an ominous prognostic factor and cor-
relates with generally increased hospital mortality.12
Concept
Here’s a new theory based on the small intestine. This 
internal organ has a length of about 7 m and a surface 
area of about 0.25 m2 if opened longitudinally. However, 
folds, villi and microvilli make the absorptive surface 
much larger than this. Indeed, calculations from histol-
ogy and fractal geometry estimate the true surface area 
at about 250 m2.13 This substantial surface area, similar 
to the size of a tennis court, is a thousand times larger 
than is apparent by simple inspection.
The large surface area makes the small intestine an ef-
fective structure for absorbing diverse types of food. No 
surprise,  therefore,  that  healthy  people  can  assimilate 
massive quantities of meat, vegetables, fruit and other 
exotica in a single day. No surprise, as well, that malab-
sorption diseases are rare even among older adults. From 
an  evolutionary  perspective,  an  organism  with  fallible absorption would face harsh selective disadvantages in a 
competitive environment that had limited food. 
This situation changes during surgery or other acute 
stresses. At such times, eating is dispensable and the 
maintenance of the vital organs becomes the priority of 
physiological responses. The autonomic nervous system 
sacrifices  perfusion  to  the  small  intestine  (along  with 
the skin, hair follicles and other less critical organs) in 
favour of the brain and heart (which have little reserve 
capacity). Furthermore, the diversion is regulated such 
that the small intestine still receives some blood and be-
comes hypoperfused but not infarcted. 
A compromised small intestine may eventually return 
fully to normal function, but this takes time (especially if 
stresses are ongoing). In the interim, the small intestine 
might malfunction and switch from being a remarkable 
absorptive surface to becoming a counterproductive ex-
cretory surface. That is, blood continues to flow through 
the splanchnic circulation, but with capillary exchange 
occurring in the wrong direction: nutrients leak from 
the plasma down their concentration gradient into the 
lumen of the intestine.14
Evidence
Capillary leak is defined as an excessive loss of fluid and 
protein into the interstitial space as a result of endothel-
ial cell dysfunction. This is one of the most widely studied 
and clinically apparent consequences of ischemia-reper-
fusion vessel injury and other acute inflammatory reac-
tions.15 Both apoptosis and necrosis of endothelial cells 
may contribute to capillary leak, as well as the inflamma-
tory mediators released from activated neutrophils such 
as tumour necrosis factor alpha and interleukin beta.16–18 
It would not take much capillary leak in the splanch-
nic  circulation  to  cause  a  profound  drop  in  albumin. 
Total  body  albumin  synthesis  is  believed  to  be  about   
13 g per day.19 Under completely normal circumstances, 
an intact small intestine accounts for about 10% of daily 
losses (stemming from endothelial gaps and other im-
perfections). If the entire 250 m2 of intestinal lining were 
to become permeable, therefore, the patient could have 
a rapid, large and ongoing decrease in albumin (Fig. 1). 
The wasting might also be widespread. A patient could 
leak IgG along with other immunoglobulins and become 
prone to pneumonia. A patient could leak antithrombin 
III along with other anticoagulants and become prone 
to thromboembolism. A patient could leak thyroglobulin 
along with other carrier proteins and become prone to 
adverse drug reactions. Meanwhile, and in silence, bowel 
microbes might consume plentiful substrate, proliferate 
to high numbers, and predispose the patient to sepsis.
Of  course,  because  simple  molecules  can  be  re-
absorbed, the wasting is not universal. That is, reabsorp-
tion of sodium is relatively non-competitive, so that the 
patient does not develop salt depletion.20 Similarly, water 
reabsorption might be preserved in the large intestine, 
particularly if a concurrent ileus prolongs contact time. 
The net effect from intestinal capillary leak, therefore, 
might be loss of complex plasma constituents but no ma-
jor diarrhea (akin to the protein loss from inflammatory 
bowel disease).21–23 
Animal  models  of  protein-losing  enteropathy  typ-
ically induce intestinal mucosa failure by the injection of 
inflammatory cytokines (or interferon-gamma) into syn-
decan-1–deficient mice. The result is a rapid leak of serum 
proteins  into  the  stool,  causing  profound  hypoalbumi-
nemia.24 Microscopically, the lesions appear as defective 
intercellular junctions between epithelial cells at the lam-
ina propria.25 Interestingly, some agents show promise in 
reversing the intestinal barrier dysfunction in mice.26
Controversies
The  irony  of  protein-losing  enteropathy  is  that  many 
physicians think they have never seen a case. House staff 
spend months on hospital wards continually treating pa-
tients with an unexplained low serum albumin, yet rarely 
list this diagnosis. Clinicians read clinical trials and me-
ta-analyses about albumin transfusions being relatively 
unsuccessful and expensive, yet still remain tempted to 
order such replacements.7,27,28 Trainees repeatedly check 
the normality of liver or kidney function and still miss 
the diagnosis. 
Physiologic stress responses are familiar to most clin-
icians,  such  as  when  a  patient  manifests  tachycardia, 
diaphoresis or pallor. This classic appearance is often 
described as “the patient looked acutely ill.” However, 
another element of the stress response is almost univer-
sal yet is not visible to clinicians: namely, the 50% (or 
greater) reduction in splanchnic blood flow that accom-
panies even small stresses.29 Such large reductions in in-
testinal blood flow typically go unnoticed except in the 
most blatant clinical cases.30 
The reality may be that surgeons, intensivists, trauma-
tologists  and  other  physicians  have  seen  hundreds  of 
cases of protein-losing enteropathy but failed to recog-
nize  this  potential  contributor  to  hypoalbuminemia. 
They have also seen patients die from pneumonia, throm-
boembolism and sepsis that may reflect complications of 
other unmeasured lost plasma proteins.31 This idea can 
also explain why parenteral nutrition rarely normalizes 
the serum albumin (although it can stop a bad situation 
from becoming worse). 
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whereby blood constituents escape to inert extravascular 
locations during shock.32 The main difference is to shift 
some attention away from the skin (with a surface < 2 m2 
and a somewhat inelastic capacity) to the intestines (with 
a surface > 200 m2 and a potentially endless capacity). 
This idea can also explain why albumin infusions can 
be ineffective and give pause to pharmacies that spend 
more than a quarter of their budget on such infusions.33
The idea also helps solve an anomaly revealed by past 
research. Namely, major surgery leads to a roughly 100% 
increase in the transcapillary escape rate of albumin from 
the vascular space into the skin.34 This increased egress 
of albumin should lead to increased lymphatic return to 
the intravascular compartment. However, studies of al-
bumin kinetics during major surgery have shown a drop 
in lymphatic flow and lymphatic albumin concentration.35 
Apparently, albumin is not just shifted into the skin. 
As  a  mechanism  that  would 
explain  hypoalbuminemia,  oc-
cult  protein-losing  also  differs 
from  the  speculation  that  direct 
protein  catabolism  by  vascular 
endothelium or other body organs 
is the cause.36 Such speculations 
have  some  basis,  since  normal 
skin and muscle account for about 
7  g  of  albumin  degradation  per 
day.37 Yet catabolic states tend to 
down-regulate, not increase, skin 
and muscle metabolism. The liver, 
brain, heart and other major or-
gans have a much lower ability to 
metabolize albumin.38 
Capillary leak with intestinal loss 
also explains the mathematics of the 
situation. Consider a patient with a 
drop in albumin from 40 g/L to 20 
g/L, a plasma volume of 3 L, and an 
extravascular space of 6 L. Hence, 
about  180  g  of  albumin  appears 
lost ([40 − 20] × [3 + 6]). Doubling 
the extravascular space to 12 L (an 
extreme  assumption  that  exceeds 
the  conditions  of  animal  studies) 
would not account for a reduction of 
this magnitude.8 Moreover, clinical 
studies have found that the infusion 
of  similar  quantities  of  albumin 
failed to normalize a patient’s albu-
min level.39–41 
Intestinal capillary leak also explains why MEDLINE 
has  not  once  described  a  survivor  with  reabsorptive 
hyperalbuminemia. Many patients recover from catas-
trophic illnesses and reabsorb factors from inert spaces. 
Survivors, for example, may develop unwanted adverse 
effects when they mobilize subcutaneous insulin or mor-
phine. Reabsorbtion of sequestered saline can also lead 
to dramatic fluid overload. Yet patients do not seem to 
develop rebound hyperalbuminemia, suggesting that the 
albumin is gone. 
Application
One way to test this idea would be to collect stool after 
surgery and correlate decreases in serum albumin with 
increases in fecal albumin. Such research has not been 
conducted, because degradation by coliforms prevents al-
bumin from surviving transit in the colon. This destruc-
tion of evidence explains why dictionaries offer a term for 
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Figure 1: Protein loss in intact and leaky small intestine. The left panel shows in-
tact mucosal lining cells of the small intestine with ongoing submucosal vascular perfusion and 
minimal loss of plasma constituents in the lumen of the gastrointestinal tract. The right panel 
shows leaky mucosal lining cells of the small intestine with ongoing submucosal vascular endo-
thelial gaps and ongoing loss of plasma constituents into the lumen of the gastrointestinal tract. 
Note that the increased losses of plasma constituents also provide a substrate for aerobic and 
anaerobic bacterial proliferation in the lumen. The red particles depict plasma constituents such 
as proteins, immunoglobulins and other middle molecules; the blue particles depict lumenal 
contents such as bacteria, fungi and other potential toxins.
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estool mixed with blood but not for stool mixed with pro-
tein (unlike the kidneys, which can manifest both hema-
turia and proteinuria). Perhaps the term “proteinochezia” 
could be coined to denote increased fecal protein.  
An  indirect  approach  for  detecting  fecal  albumin 
could involve stool studies for alpha-1-antitrypsin. This 
protein is another plasma constituent that resists coli-
form catabolism, but it might also leak into the intestinal 
lumen. The main disadvantages of stool tests for alpha-
1-antitrypsin are of a practical nature. First, postopera-
tive ileus can create problems in interpreting the results 
observed.42 Second, specimen collection and handling is 
unappealing to clinical and laboratory staff. Third, most 
institutions are not equipped with the necessary analytic 
technology. 
Medical imaging tests might also help increase our 
understanding of patients with postoperative hypoalbu-
minemia. Specifically, scanning individuals 24 h after 
an infusion of technetium 99m–labelled human serum 
albumin can be a reliable method for detecting tracer 
exudation in the gut for those with overt protein-losing 
enteropathy.43 In some cases the sites of protein loss can 
be demonstrated. The main drawbacks with such scan-
ning are cost, availability, resolution and potential ad-
verse reactions. 
Many avenues are also available for refutation. For 
example, perhaps the lack of efficacy of albumin replace-
ment therapy stems from unwanted storage lesions. If 
so, better replacement therapy might exonerate the role 
of intestinal lumen leakage (however, modern colloids 
have not been more effective than albumin infusions to 
date).44 Alternatively, perhaps albumin degradation re-
flects oxidation in the body rather than catabolism by in-
testinal microbes. If so, perhaps a systemic antioxidant 
might prevent postoperative hypoalbuminemia.45  
A more radical way to test the idea might be to dis-
cover a new intervention that maintains capillary integ-
rity  throughout  the  intestinal  mucosa.  However,  such 
a revolutionary agent might cause widespread changes 
to the inflammatory cascade and unwanted effects else-
where. An impaired intestine can eventually heal per-
fectly, whereas a compromised brain or heart can cause 
permanent disability. A temporary interval of intestinal 
capillary leak may be an unfortunate but necessary com-
promise in preserving the critical organs. 
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